Microsatellite instability in colorectal cancer—the stable evidence

E Vilar, SB Gruber - Nature reviews Clinical oncology, 2010 - nature.com
Microsatellite instability (MSI) is the molecular fingerprint of a deficient mismatch repair
system. Approximately 15% of colorectal cancers (CRC) display MSI owing either to …

Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: a narrative review

WJ Mei, M Mi, J Qian, N Xiao, Y Yuan… - Frontiers in …, 2022 - frontiersin.org
Colorectal cancers (CRCs) with high microsatellite instability (MSI-H) and deficient mismatch
repair (dMMR) show molecular and clinicopathological characteristics that differ from those …

Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers

E Jiagge, DX Jin, JY Newberg, T Perea-Chamblee… - Cancer cell, 2023 - cell.com
Cancer genomes from patients with African (AFR) ancestry have been poorly studied in
clinical research. We leverage two large genomic cohorts to investigate the relationship …

Clinicopathological and protein characterization of BRAF‐ and K‐RAS‐mutated colorectal cancer and implications for prognosis

I Zlobec, MP Bihl, H Schwarb… - … journal of cancer, 2010 - Wiley Online Library
Recent evidence highlights the potential prognostic and predictive value of BRAF and K‐
RAS gene alterations in patients with colorectal cancer. However, a comprehensive …

Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study

S Kirzin, L Marisa, R Guimbaud, A De Reynies… - PloS one, 2014 - journals.plos.org
Sporadic early onset colorectal carcinoma (EOCRC) which has by definition no identified
hereditary predisposition is a growing problem that remains poorly understood. Molecular …

TGF-β signaling alterations and colon cancer

N Bellam, B Pasche - Cancer genetics, 2010 - Springer
Colorectal cancer is the second most common cause of cancer-related death in the United
States. Twin studies suggest that 35% of all colorectal cancer cases are inherited. High …

Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening—a report from the American Society of Clinical Oncology

NJ Petrelli, EP Winer, J Brahmer, S Dubey… - Journal of Clinical …, 2009 - ascopubs.org
A MESSAGE FROM ASCO'S PRESIDENT As this report demonstrates—and as history
shows—investment in clinical cancer research pays off. Since 1990, cancer mortality rates …

MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features

X Li, X Yao, Y Wang, F Hu, F Wang, L Jiang, Y Liu… - PloS one, 2013 - journals.plos.org
Purpose To describe the frequency of MLH1 promoter methylation in colorectal cancer
(CRC); to explore the associations between MLH1 promoter methylation and …

Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients

HH Yoon, Q Shi, SR Alberts… - Journal of the …, 2015 - academic.oup.com
Background: It is unknown if, after controlling for clinicopathologic variables and treatment,
racial disparities in colon cancer outcomes persist. Molecular marker analysis in North …

Implementing prognostic and predictive biomarkers in CRC clinical trials

S Van Schaeybroeck, WL Allen… - Nature reviews Clinical …, 2011 - nature.com
Over the past two decades, several protein and genomic markers have refined the
prognostic information of colorectal cancer (CRC) and helped to predict which patient group …